CVS Health Corp. carries a market capitalization of 120.78B, placing it among publicly traded companies globally. Its enterprise value stands at 194.75B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 120.78B |
| Enterprise Value | 194.75B |
CVS Health Corp. currently has 1.28B shares outstanding.
| Shares Outstanding | 1.28B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CVS Health Corp. trades at a trailing price-to-earnings ratio of 26.93. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 1.66.
| PE Ratio | 26.93 |
| PS Ratio | 0.32 |
| PB Ratio | 1.66 |
| P/TBV Ratio | -4.35 |
| P/FCF Ratio | 7.43 |
| P/OCF Ratio | 8.91 |
On an enterprise value basis, CVS Health Corp. trades at an EV/EBITDA multiple of 10.51 and an EV/FCF ratio of 9.54. The EV/Sales ratio of 0.47 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.90 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.47 |
| EV / EBITDA | 10.51 |
| EV / EBIT | 13.90 |
| EV / FCF | 9.54 |
CVS Health Corp. maintains a current ratio of 0.87, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 95.50, indicating elevated leverage, while an interest coverage ratio of 5.98 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.87 |
| Quick Ratio | 0.62 |
| Debt / Equity | 95.50 |
| Debt / EBITDA | 4.12 |
| Interest Coverage | 5.98 |
CVS Health Corp. posts a return on equity of 6.23 and a return on invested capital of 7.48.
| Return on Equity (ROE) | 6.23 |
| Return on Assets (ROA) | 1.91 |
| Return on Invested Capital (ROIC) | 7.48 |
| Return on Capital Employed (ROCE) | 4.75 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 20.32 |
Over the trailing twelve months, CVS Health Corp. has paid 902.00M in income taxes, reflecting an effective tax rate of 15.59.
| Income Tax | 902.00M |
| Effective Tax Rate | 15.59 |
CVS Health Corp.'s stock has gained approximately 26.247% over the past 52 weeks. The 50-day moving average sits at 100.10, while the 200-day moving average is 86.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | 26.247% |
| 50-Day Moving Average | 100.10 |
| 200-Day Moving Average | 86.92 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CVS Health Corp. generated 415.09B in revenue and converted that into 4.89B in net income, yielding earnings per share of 3.82. EBITDA reached 18.54B, while operating income came in at 14.01B.
| Revenue | 415.09B |
| Gross Profit | 58.75B |
| Operating Income | 14.01B |
| Pretax Income | 5.79B |
| Net Income | 4.89B |
| EBITDA | 18.54B |
| EBIT | 14.01B |
| Earnings Per Share (EPS) | 3.82 |
CVS Health Corp. holds 13.96B in cash and equivalents against 76.31B in total debt, resulting in a net debt position of 50.08B. Total book value stands at 79.70B, with working capital of -11.69B providing operational flexibility.
| Cash & Cash Equivalents | 13.96B |
| Total Debt | 76.31B |
| Net Debt | 50.08B |
| Equity (Book Value) | 79.70B |
| Book Value Per Share | 62.36 |
| Working Capital | -11.69B |
CVS Health Corp. produced 14.78B in operating cash flow over the past twelve months. After subtracting -3.02B in capital expenditures, free cash flow totaled 11.76B - equivalent to 9.24 per share.
| Operating Cash Flow | 14.78B |
| Capital Expenditures | -3.02B |
| Free Cash Flow | 11.76B |
| FCF Per Share | 9.24 |
CVS Health Corp. operates with a gross margin of 14.15, reflecting its pricing power and cost economics. The operating margin of 3.38 and net profit margin of 1.18 provide insight into operational efficiency.
| Gross Margin | 14.15 |
| Operating Margin | 3.38 |
| Pretax Margin | 1.39 |
| Profit Margin | 1.18 |
| EBITDA Margin | 4.47 |
The company's payout ratio of 70.00 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 2.68 |
| Dividend Yield | N/A |
| Payout Ratio | 70.00 |
| Shareholder Yield | 6.37 |
| FCF Yield | 13.47 |
CVS Health Corp.'s most recent stock split took place on June 7, 2005 with a 1:2 split ratio.
| Last Split Date | 6/7/2005 |
| Split Ratio | 1:2 |
CVS Health Corp. posts an Altman Z-Score of 4.21, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.21 |